Search Results - "Peniket, A"

Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience by O'Hare, P, Lucchini, G, Cummins, M, Veys, P, Potter, M, Lawson, S, Vora, A, Wynn, R, Peniket, A, Kirkland, K, Pearce, R, Perry, J, Amrolia, P J

“…We report outcomes for 44 children who underwent stem cell transplantation (SCT) for refractory AML in the UK between 2000 and 2012. Median age at SCT was 11.5…”
Get full text

High proportions of regulatory T cells in PBSC grafts predict improved survival after allogeneic haematopoietic SCT by Danby, R D, Zhang, W, Medd, P, Littlewood, T J, Peniket, A, Rocha, V, Roberts, D J

“…Regulatory T cells (Tregs) modulate immune responses and improve survival in murine transplant models. However, whether the Treg content of allogeneic cell…”
Get full text

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation by PENIKET, A. J, RUIZ DE ELVIRA, M. C, CORNELISSEN, J, SCHMITZ, N, EUROPEA, A. H. Goldstone On Behalf Of, TAGHIPOUR, G, CORDONNIER, C, GLUCKMAN, E, DE WITTE, T, SANTINI, G, BLAISE, D, GREINIX, H, FERRANT, A

“…The role of allogeneic bone marrow transplantation in lymphoma remains uncertain. We have analyzed 1185 allogeneic transplants for lymphoma reported to the…”
Get full text

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT by Robin, M, Porcher, R, Zinke-Cerwenka, W, van Biezen, A, Volin, L, Mufti, G, Craddock, C, Finke, J, Richard, C, Passweg, J, Peniket, A, Maertens, J, Sucak, G, Gedde-Dahl, T, Vitek, A, Nagler, A, Blaise, D, Beelen, D, Maillard, N, Schwerdtfeger, R, de Witte, T, Kroger, N

“…We report a retrospective analysis of 246 myelodysplastic syndrome (MDS) patients in the EBMT (The European Society for Blood and Marrow Transplantation)…”
Get full text

Provision of cellular blood components to CMV‐seronegative patients undergoing allogeneic stem cell transplantation in the UK: survey of UK transplant centres by Morton, S., Peniket, A., Malladi, R., Murphy, M. F.

“…SUMMARY Objectives To identify current UK practice with regards to provision of blood components for cytomegalovirus (CMV)‐seronegative, potential, allogeneic…”
Get full text

Variations in practice in UK transplant centers: results of a related donor care survey by Anthias, C, Peniket, A, Kirkland, K, Madrigal, J A, Shaw, B E

Get full text

Autologous hematopoietic cell transplantation (autoHCT) for T‐cell/histiocyte‐rich large B‐cell lymphoma (THRLBCL): An EBMT Lymphoma Working Party study by Renders, S., Finel, H., Ngoya, M., Boumendil, A., Schaap, N., Ghesquieres, H., Bloor, A., Pérez‐Simón, J. A., Huynh, A., Kobbe, G., Collin, M., Busca, A., Helbig, G., Aljurf, M., Daskalakis, M., Schroers, R., Carpenter, B., Rubio, M. T., Peniket, A., Sureda, A., Schmitz, N., Glass, B., Dreger, P.

Get full text

Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes by Miller, P D E, de Silva, T I, Skinner, R, Gilleece, M, Peniket, A, Hamblin, A, Greenfield, D, Anthias, C, Peggs, K, Madrigal, A, Snowden, J A

Get full text

Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients by Matin, R.N., Danby, R., Gibbons, E., Venning, V., Rowley, L., Barton, D., Pawson, R., Littlewood, T., Reed, J.R., Peniket, A.

Get full text

Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes by Hamblin, A, Greenfield, D M, Gilleece, M, Salooja, N, Kenyon, M, Morris, E, Glover, N, Miller, P, Braund, H, Peniket, A, Shaw, B E, Snowden, J A

“…Despite international guidelines, optimal delivery models of late effects (LE) services for HSCT patients are unclear from the clinical, organizational and…”
Get full text

More than skin deep? Emerging therapies for chronic cutaneous GVHD by Rodgers, C J, Burge, S, Scarisbrick, J, Peniket, A

“…The options for treating skin disease after haemopoietic progenitor cell transplant (HPCT) have broadened considerably over the last decade to include much…”
Get full text

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party by Scheid, C, de Wreede, L, van Biezen, A, Koenecke, C, Göhring, G, Volin, L, Maertens, J, Finke, J, Passweg, J, Beelen, D, Cornelissen, J J, Itälä-Remes, M, Chevallier, P, Russell, N, Petersen, E, Milpied, N, Richard Espiga, C, Peniket, A, Sierra, J, Mufti, G, Crawley, C, Veelken, J H, Ljungman, P, Cahn, J Y, Alessandrino, E P, de Witte, T, Robin, M, Kröger, N

“…The International Prognostic Scoring System has been revised (IPSS-R) to predict prognosis of patients with myelodysplastic syndromes at diagnosis. To validate…”
Get full text

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD by Dignan, F L, Greenblatt, D, Cox, M, Cavenagh, J, Oakervee, H, Apperley, J F, Fielding, A K, Pagliuca, A, Mufti, G, Raj, K, Marks, D I, Amrolia, P, Peniket, A, Medd, P, Potter, M N, Shaw, B E, Scarisbrick, J J

“…Extracorporeal photopheresis (ECP) has become a recognised treatment for steroid-refractory chronic GVHD (cGVHD), but the optimal frequency and duration of…”
Get full text

Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes by Miller, P D E, de Silva, T I, Skinner, R, Gilleece, M, Peniket, A, Hamblin, A, Greenfield, D, Anthias, C, Peggs, K, Madrigal, A, Snowden, J A

“…This corrects the article DOI: 10.1038/bmt.2016.362…”
Get full text

Transfusion of CMV‐unselected blood components may lead to inappropriate donor selection for patients subsequently undergoing allogeneic stem cell transplant by Morton, S., Danby, R., Rocha, V., Peniket, A., Murphy, M. F.

“…SUMMARY Objectives To establish whether passive transfer of cytomegalovirus (CMV) IgG via transfusion results in ambiguous serostatus in patients undergoing…”
Get full text

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT by Robin, M, Porcher, R, Zinke-Cerwenka, W, van Biezen, A, Volin, L, Mufti, G, Craddock, C, Finke, J, Richard, C, Passweg, J, Peniket, A, Maertens, J, Sucak, G, Gedde-Dahl, T, Vitek, A, Nagler, A, Blaise, D, Beelen, D, Maillard, N, Schwerdtfeger, R, de Witte, T, Kroger, N

“…This corrects the article DOI: 10.1038/bmt.2016.266…”
Get full text

Transfusion in CMV seronegative T‐depleted allogeneic stem cell transplant recipients with CMV‐unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience by Hall, S., Danby, R., Osman, H., Peniket, A., Rocha, V., Craddock, C., Murphy, M., Chaganti, S.

“…SUMMARY Objectives To establish rates of cytomegalovirus (CMV) transmission with use of CMV‐unselected (CMV‐U), leukocyte‐reduced blood components transfused…”
Get full text

Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT by Brierley, C K, Littlewood, T J, Peniket, A J, Gregg, R, Ward, J, Clark, A, Parker, A, Malladi, R, Medd, P

“…The impact of ABO incompatibility on clinical outcomes following haematopoietic SCT (HSCT) remains controversial. This retrospective study assessed the effect…”
Get full text

Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD by Dignan, F L, Aguilar, S, Scarisbrick, J J, Shaw, B E, Potter, M N, Cavenagh, J, Apperley, J F, Fielding, A K, Pagliuca, A, Raj, K, Marks, D I, Peniket, A, Crawley, C, Koh, M B, Child, F J

“…There are few prospective studies evaluating the role of extracorporeal photopheresis (ECP) in chronic GVHD (cGVHD) and only occasional reports of the effect…”
Get full text

Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study by Medd, P G, Peniket, A J, Littlewood, T J, Pearce, R, Perry, J, Kirkland, K E, Shaw, B E, Potter, M N, Craddock, C F, Milligan, D W, Fielding, A K, Marks, D I, Cook, G

“…Myeloablative allo-SCT decreases relapse incidence (RI) in ALL. Reduced intensity conditioning (RIC) may extend allo-SCT to older and less fit patients…”
Get full text